 Microfluidics Market Insights, Competitive Landscape, and Market Forecast - 2033
The global microfluidics market is steadily advancing as the demand for compact, efficient, and high-precision analytical technologies rises across healthcare and life sciences. Microfluidics techn... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global microfluidics market is steadily advancing as the demand for compact, efficient, and high-precision analytical technologies rises across healthcare and life sciences. Microfluidics technology, which enables the manipulation of minute fluid volumes within microscale channels, has become a cornerstone in modern diagnostics, drug discovery, and research applications. Its ability to deliver rapid, accurate, and cost-efficient results is driving its widespread adoption across both medical and non-medical sectors.Market Insights The microfluidics market is expected to grow from USD 27.3 billion in 2026 to USD 46.5 billion by 2033, registering a CAGR of 7.90% during the forecast period. This expansion reflects the increasing integration of microfluidic systems into clinical diagnostics, biotechnology workflows, and environmental monitoring solutions. The growing use of lab-on-a-chip technologies and organ-on-chip systems is further enhancing the efficiency of experimental and diagnostic processes. Microfluidic platforms are gaining traction due to their ability to reduce reagent consumption, minimize operational costs, and improve analytical accuracy. As laboratories and healthcare providers shift toward automation and miniaturization, microfluidics is emerging as a critical enabler of next-generation diagnostic solutions. Market Drivers A primary driver of the microfluidics market is the rising need for rapid diagnostic tools, particularly in the context of increasing chronic and infectious diseases. Microfluidic devices enable quick and reliable testing, making them highly suitable for point-of-care applications and decentralized healthcare systems. The expanding pharmaceutical and biotechnology industries also play a crucial role in market growth. Microfluidics facilitates high-throughput screening, drug formulation, and molecular analysis, accelerating the drug development process while reducing costs. This capability is especially valuable in an era where speed and precision are essential for bringing new therapies to market. Technological advancements in materials and fabrication processes are further supporting market expansion. The adoption of cost-effective materials such as polymers and PDMS is enabling scalable production of microfluidic devices, making them more accessible across various industries. Business Opportunity Significant growth opportunities exist within the microfluidics market, particularly in the field of personalized medicine. The demand for tailored healthcare solutions is driving the development of advanced diagnostic platforms that can deliver patient-specific insights. Technologies such as lab-on-a-chip and organ-on-chip are revolutionizing disease modeling and drug testing, offering more accurate and ethical alternatives to conventional methods. Emerging markets present another key opportunity. Increasing healthcare investments, improving infrastructure, and rising awareness of advanced technologies are fueling demand in regions such as Asia Pacific and Latin America. Companies that focus on developing affordable and portable solutions are well-positioned to capitalize on these expanding markets. Additionally, the convergence of microfluidics with digital health technologies is opening new avenues for innovation. Integration with wearable devices and remote monitoring systems is enabling continuous health tracking, supporting the global transition toward preventive and connected healthcare. Region Analysis North America continues to lead the microfluidics market, driven by strong research capabilities, high healthcare spending, and early adoption of advanced technologies. The presence of major industry players further strengthens the region’s market position. Europe maintains a significant share, supported by robust academic research, government initiatives, and a growing focus on precision medicine. The region’s established healthcare infrastructure is facilitating the widespread implementation of microfluidic technologies. Asia Pacific is expected to experience the fastest growth over the forecast period. Rapid urbanization, expanding healthcare systems, and increasing investments in biotechnology are driving demand in countries such as China, India, and Japan. The region’s large population base also contributes to the rising need for efficient diagnostic solutions. Latin America and the Middle East and Africa are gradually adopting microfluidic technologies, supported by improving healthcare infrastructure and growing awareness. Although these regions are still developing, they offer considerable long-term growth potential. Key Players The competitive landscape of the microfluidics market includes a mix of established corporations and specialized technology providers focusing on innovation and strategic expansion. Prominent players in the market include: • Thermo Fisher Scientific Inc. • Danaher Corporation • Agilent Technologies, Inc. • Bio-Rad Laboratories, Inc. • PerkinElmer, Inc. • Standard BioTools Inc. • Dolomite Microfluidics • Elveflow • Sphere Fluidics Limited • Micronit Microtechnologies B.V. • uFluidix • Abbott Laboratories • F. Hoffmann-La Roche Ltd. • Becton, Dickinson and Company • Illumina, Inc. These companies are continuously investing in research and development, launching innovative products, and forming strategic partnerships to strengthen their market presence and expand globally. Conclusion The microfluidics market is poised for consistent growth, supported by technological advancements, increasing healthcare demands, and expanding application areas. As industries continue to prioritize efficiency, accuracy, and cost-effectiveness, microfluidics will remain a key technology driving innovation in diagnostics and life sciences. With strong momentum and ongoing investments, the market is expected to witness sustained expansion through 2033. Segmentation By Technology • Medical/Healthcare o PCR & RT-PCR o Gel Electrophoresis o Microarrays o ELISA o Others • Non-medical By Material • Silicon • Glass • Polymer • PDMS • Others By Application • Lab-on-a-chip o Medical o Non-Medical • Organs-on-chips o Medical o Non-Medical • Continuous Flow Microfluidics o Medical o Non-Medical • Optofluidics And Microfluidics o Medical o Non-Medical • Acoustofluidics And Microfluidics o Medical o Non-Medical • Electrophoresis And Microfluidics o Medical o Non-Medical By Region • North America • Europe • Asia Pacific • Latin America • Middle East and Africa Table of Contents1. Executive Summary1.1. Global Microfluidics Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Microfluidics Market Outlook, 2020-2033 3.1. Global Microfluidics Market Outlook, by Technology, Value (US$ Bn), 2020-2033 3.1.1. Medical/Healthcare 3.1.1.1. PCR & RT-PCR 3.1.1.2. Gel Electrophoresis 3.1.1.3. Microarrays 3.1.1.4. ELISA 3.1.1.5. Others 3.1.2. Non-medical 3.2. Global Microfluidics Market Outlook, by Material, Value (US$ Bn), 2020-2033 3.2.1. Silicon 3.2.2. Glass 3.2.3. Polymer 3.2.4. PDMS 3.2.5. Others 3.3. Global Microfluidics Market Outlook, by Application, Value (US$ Bn), 2020-2033 3.3.1. Lab-on-a-chip 3.3.2. Organs-on-chips 3.3.3. Continuous Flow Microfluidics 3.3.4. Optofluidics And Microfluidics 3.3.5. Acoustofluidics And Microfluidics 3.3.6. Electrophoresis And Microfluidics 3.4. Global Microfluidics Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America Microfluidics Market Outlook, 2020-2033 4.1. North America Microfluidics Market Outlook, by Technology, Value (US$ Bn), 2020-2033 4.1.1. Medical/Healthcare 4.1.1.1. PCR & RT-PCR 4.1.1.2. Gel Electrophoresis 4.1.1.3. Microarrays 4.1.1.4. ELISA 4.1.1.5. Others 4.1.2. Non-medical 4.2. North America Microfluidics Market Outlook, by Material, Value (US$ Bn), 2020-2033 4.2.1. Silicon 4.2.2. Glass 4.2.3. Polymer 4.2.4. PDMS 4.2.5. Others 4.3. North America Microfluidics Market Outlook, by Application, Value (US$ Bn), 2020-2033 4.3.1. Lab-on-a-chip 4.3.2. Organs-on-chips 4.3.3. Continuous Flow Microfluidics 4.3.4. Optofluidics And Microfluidics 4.3.5. Acoustofluidics And Microfluidics 4.3.6. Electrophoresis And Microfluidics 4.4. North America Microfluidics Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.4.1. U.S. Microfluidics Market Outlook, by Technology, 2020-2033 4.4.2. U.S. Microfluidics Market Outlook, by Material, 2020-2033 4.4.3. U.S. Microfluidics Market Outlook, by Application, 2020-2033 4.4.4. Canada Microfluidics Market Outlook, by Technology, 2020-2033 4.4.5. Canada Microfluidics Market Outlook, by Material, 2020-2033 4.4.6. Canada Microfluidics Market Outlook, by Application, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe Microfluidics Market Outlook, 2020-2033 5.1. Europe Microfluidics Market Outlook, by Technology, Value (US$ Bn), 2020-2033 5.1.1. Medical/Healthcare 5.1.1.1. PCR & RT-PCR 5.1.1.2. Gel Electrophoresis 5.1.1.3. Microarrays 5.1.1.4. ELISA 5.1.1.5. Others 5.1.2. Non-medical 5.2. Europe Microfluidics Market Outlook, by Material, Value (US$ Bn), 2020-2033 5.2.1. Silicon 5.2.2. Glass 5.2.3. Polymer 5.2.4. PDMS 5.2.5. Others 5.3. Europe Microfluidics Market Outlook, by Application, Value (US$ Bn), 2020-2033 5.3.1. Lab-on-a-chip 5.3.2. Organs-on-chips 5.3.3. Continuous Flow Microfluidics 5.3.4. Optofluidics And Microfluidics 5.3.5. Acoustofluidics And Microfluidics 5.3.6. Electrophoresis And Microfluidics 5.4. Europe Microfluidics Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.4.1. Germany Microfluidics Market Outlook, by Technology, 2020-2033 5.4.2. Germany Microfluidics Market Outlook, by Material, 2020-2033 5.4.3. Germany Microfluidics Market Outlook, by Application, 2020-2033 5.4.4. Italy Microfluidics Market Outlook, by Technology, 2020-2033 5.4.5. Italy Microfluidics Market Outlook, by Material, 2020-2033 5.4.6. Italy Microfluidics Market Outlook, by Application, 2020-2033 5.4.7. France Microfluidics Market Outlook, by Technology, 2020-2033 5.4.8. France Microfluidics Market Outlook, by Material, 2020-2033 5.4.9. France Microfluidics Market Outlook, by Application, 2020-2033 5.4.10. U.K. Microfluidics Market Outlook, by Technology, 2020-2033 5.4.11. U.K. Microfluidics Market Outlook, by Material, 2020-2033 5.4.12. U.K. Microfluidics Market Outlook, by Application, 2020-2033 5.4.13. Spain Microfluidics Market Outlook, by Technology, 2020-2033 5.4.14. Spain Microfluidics Market Outlook, by Material, 2020-2033 5.4.15. Spain Microfluidics Market Outlook, by Application, 2020-2033 5.4.16. Russia Microfluidics Market Outlook, by Technology, 2020-2033 5.4.17. Russia Microfluidics Market Outlook, by Material, 2020-2033 5.4.18. Russia Microfluidics Market Outlook, by Application, 2020-2033 5.4.19. Rest of Europe Microfluidics Market Outlook, by Technology, 2020-2033 5.4.20. Rest of Europe Microfluidics Market Outlook, by Material, 2020-2033 5.4.21. Rest of Europe Microfluidics Market Outlook, by Application, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Microfluidics Market Outlook, 2020-2033 6.1. Asia Pacific Microfluidics Market Outlook, by Technology, Value (US$ Bn), 2020-2033 6.1.1. Medical/Healthcare 6.1.1.1. PCR & RT-PCR 6.1.1.2. Gel Electrophoresis 6.1.1.3. Microarrays 6.1.1.4. ELISA 6.1.1.5. Others 6.1.2. Non-medical 6.2. Asia Pacific Microfluidics Market Outlook, by Material, Value (US$ Bn), 2020-2033 6.2.1. Silicon 6.2.2. Glass 6.2.3. Polymer 6.2.4. PDMS 6.2.5. Others 6.3. Asia Pacific Microfluidics Market Outlook, by Application, Value (US$ Bn), 2020-2033 6.3.1. Lab-on-a-chip 6.3.2. Organs-on-chips 6.3.3. Continuous Flow Microfluidics 6.3.4. Optofluidics And Microfluidics 6.3.5. Acoustofluidics And Microfluidics 6.3.6. Electrophoresis And Microfluidics 6.4. Asia Pacific Microfluidics Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.4.1. China Microfluidics Market Outlook, by Technology, 2020-2033 6.4.2. China Microfluidics Market Outlook, by Material, 2020-2033 6.4.3. China Microfluidics Market Outlook, by Application, 2020-2033 6.4.4. Japan Microfluidics Market Outlook, by Technology, 2020-2033 6.4.5. Japan Microfluidics Market Outlook, by Material, 2020-2033 6.4.6. Japan Microfluidics Market Outlook, by Application, 2020-2033 6.4.7. South Korea Microfluidics Market Outlook, by Technology, 2020-2033 6.4.8. South Korea Microfluidics Market Outlook, by Material, 2020-2033 6.4.9. South Korea Microfluidics Market Outlook, by Application, 2020-2033 6.4.10. India Microfluidics Market Outlook, by Technology, 2020-2033 6.4.11. India Microfluidics Market Outlook, by Material, 2020-2033 6.4.12. India Microfluidics Market Outlook, by Application, 2020-2033 6.4.13. Southeast Asia Microfluidics Market Outlook, by Technology, 2020-2033 6.4.14. Southeast Asia Microfluidics Market Outlook, by Material, 2020-2033 6.4.15. Southeast Asia Microfluidics Market Outlook, by Application, 2020-2033 6.4.16. Rest of SAO Microfluidics Market Outlook, by Technology, 2020-2033 6.4.17. Rest of SAO Microfluidics Market Outlook, by Material, 2020-2033 6.4.18. Rest of SAO Microfluidics Market Outlook, by Application, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America Microfluidics Market Outlook, 2020-2033 7.1. Latin America Microfluidics Market Outlook, by Technology, Value (US$ Bn), 2020-2033 7.1.1. Medical/Healthcare 7.1.1.1. PCR & RT-PCR 7.1.1.2. Gel Electrophoresis 7.1.1.3. Microarrays 7.1.1.4. ELISA 7.1.1.5. Others 7.1.2. Non-medical 7.2. Latin America Microfluidics Market Outlook, by Material, Value (US$ Bn), 2020-2033 7.2.1. Silicon 7.2.2. Glass 7.2.3. Polymer 7.2.4. PDMS 7.2.5. Others 7.3. Latin America Microfluidics Market Outlook, by Application, Value (US$ Bn), 2020-2033 7.3.1. Lab-on-a-chip 7.3.2. Organs-on-chips 7.3.3. Continuous Flow Microfluidics 7.3.4. Optofluidics And Microfluidics 7.3.5. Acoustofluidics And Microfluidics 7.3.6. Electrophoresis And Microfluidics 7.4. Latin America Microfluidics Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.4.1. Brazil Microfluidics Market Outlook, by Technology, 2020-2033 7.4.2. Brazil Microfluidics Market Outlook, by Material, 2020-2033 7.4.3. Brazil Microfluidics Market Outlook, by Application, 2020-2033 7.4.4. Mexico Microfluidics Market Outlook, by Technology, 2020-2033 7.4.5. Mexico Microfluidics Market Outlook, by Material, 2020-2033 7.4.6. Mexico Microfluidics Market Outlook, by Application, 2020-2033 7.4.7. Argentina Microfluidics Market Outlook, by Technology, 2020-2033 7.4.8. Argentina Microfluidics Market Outlook, by Material, 2020-2033 7.4.9. Argentina Microfluidics Market Outlook, by Application, 2020-2033 7.4.10. Rest of LATAM Microfluidics Market Outlook, by Technology, 2020-2033 7.4.11. Rest of LATAM Microfluidics Market Outlook, by Material, 2020-2033 7.4.12. Rest of LATAM Microfluidics Market Outlook, by Application, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Microfluidics Market Outlook, 2020-2033 8.1. Middle East & Africa Microfluidics Market Outlook, by Technology, Value (US$ Bn), 2020-2033 8.1.1. Medical/Healthcare 8.1.1.1. PCR & RT-PCR 8.1.1.2. Gel Electrophoresis 8.1.1.3. Microarrays 8.1.1.4. ELISA 8.1.1.5. Others 8.1.2. Non-medical 8.2. Middle East & Africa Microfluidics Market Outlook, by Material, Value (US$ Bn), 2020-2033 8.2.1. Silicon 8.2.2. Glass 8.2.3. Polymer 8.2.4. PDMS 8.2.5. Others 8.3. Middle East & Africa Microfluidics Market Outlook, by Application, Value (US$ Bn), 2020-2033 8.3.1. Lab-on-a-chip 8.3.2. Organs-on-chips 8.3.3. Continuous Flow Microfluidics 8.3.4. Optofluidics And Microfluidics 8.3.5. Acoustofluidics And Microfluidics 8.3.6. Electrophoresis And Microfluidics 8.4. Middle East & Africa Microfluidics Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.4.1. GCC Microfluidics Market Outlook, by Technology, 2020-2033 8.4.2. GCC Microfluidics Market Outlook, by Material, 2020-2033 8.4.3. GCC Microfluidics Market Outlook, by Application, 2020-2033 8.4.4. South Africa Microfluidics Market Outlook, by Technology, 2020-2033 8.4.5. South Africa Microfluidics Market Outlook, by Material, 2020-2033 8.4.6. South Africa Microfluidics Market Outlook, by Application, 2020-2033 8.4.7. Egypt Microfluidics Market Outlook, by Technology, 2020-2033 8.4.8. Egypt Microfluidics Market Outlook, by Material, 2020-2033 8.4.9. Egypt Microfluidics Market Outlook, by Application, 2020-2033 8.4.10. Nigeria Microfluidics Market Outlook, by Technology, 2020-2033 8.4.11. Nigeria Microfluidics Market Outlook, by Material, 2020-2033 8.4.12. Nigeria Microfluidics Market Outlook, by Application, 2020-2033 8.4.13. Rest of Middle East Microfluidics Market Outlook, by Technology, 2020-2033 8.4.14. Rest of Middle East Microfluidics Market Outlook, by Material, 2020-2033 8.4.15. Rest of Middle East Microfluidics Market Outlook, by Application, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Thermo Fisher Scientific Inc. 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Danaher Corporation 9.4.3. Agilent Technologies, Inc. 9.4.4. Bio-Rad Laboratories, Inc. 9.4.5. PerkinElmer, Inc. 9.4.6. Standard BioTools Inc. 9.4.7. Dolomite Microfluidics 9.4.8. Elveflow 9.4.9. Sphere Fluidics Limited 9.4.10. Micronit Microtechnologies B.V. 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD（landscape）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
